Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.070
0.00 (0.00%)
At close: Nov 14, 2025, 4:00 PM EST
1.060
-0.010 (-0.93%)
After-hours: Nov 14, 2025, 7:38 PM EST
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $28.96 million as of November 14, 2025. Its market cap has decreased by -61.59% in one year.
Market Cap
28.96M
Enterprise Value
29.06M
1-Year Change
-61.59%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $28.96M, a decrease of -91.63%. That is a compound annual growth rate of -42.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 28.96M | -63.85% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | 346.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.91B |
| Johnson & Johnson | 470.05B |
| AbbVie | 410.92B |
| UnitedHealth Group | 308.19B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 227.85B |
| Abbott Laboratories | 223.36B |